Home

Pratik Shah

CIK 1580787 · President, CEO and Chairperson · last filed 2026-06-26

Pratik Shah is a President, CEO and Chairperson who has filed 20 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for SPRY, was dated Jun 26, 2026. Across all open-market trades the lifetime net is +$600.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $23.6M across reported positions. 4 SEC filings were submitted jointly with Pratik Shah Living Trust dated June 15, 2011.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$23.57M

Companies

4

Total Filings

20

Lifetime Open-Market Net

$600.0K

Filer Profile

Reported Address
C/O DESIGN THERAPEUTICS, INC.
6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD, CA 92011
Related Filers
Pratik Shah Living Trust dated June 15, 2011 — 4 joint filings, latest 2024-06-07
ERIC AGUIAR — 1 joint filings, latest 2013-07-17
JAMES E THOMAS — 1 joint filings, latest 2013-07-17
THOMAS MCNERNEY & PARTNERS LP — 1 joint filings, latest 2013-07-17
Alex Zisson — 1 joint filings, latest 2013-07-17
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SPRY Director 4,474,554 $4.76 $21.30M $0 7 2026-06-26
DSGN President, CEO and Chairperson 154,923 $14.63 $2.27M $500.0K 7 2026-01-05
THOR Director 0 $26.17 $0 $0 2 2020-01-24
Auspex Pharmaceuticals, Inc. (ASPX) Delisted President and CEO 0 — — $100.0K 3 2015-05-06

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-26 SPRY Grant (A) — $0 EDGAR
2026-01-05 DSGN Grant (A) — $0 EDGAR
2025-12-11 DSGN Grant (A) — $0 EDGAR
2025-11-14 SPRY Gift (G) −350,000 $0 EDGAR
2025-06-27 SPRY Grant (A) — $0 EDGAR
2025-01-06 DSGN Grant (A) — $0 EDGAR
2024-06-24 SPRY Grant (A) — $0 EDGAR
2024-06-17 SPRY Gift (G) −1,332,900 $0 EDGAR
2024-06-07 SPRY Gift (G) −1,332,950 $0 EDGAR
2023-09-05 DSGN Grant (A) — $0 EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.